FDAnews Drug Daily Bulletin

Sept. 18, 2012 | Vol. 9 No. 183

GlaxoSmithKline Submits New Application for Synflorix in EU

GlaxoSmithKline said it has submitted a regulatory application in the European Union seeking approval of an additional indication for Synflorix, a paediatric pneumococcal vaccine, for the active immunization against pneumonia caused by Streptococcus pneumoniae in infants and children from 6 weeks up to 5 years of age.
Fox Business

Register Now
Print This Page
Email This Article
RSS
Archives

Pharma Blog Watch New Report Examines Efforts to Reduce the Impact of Generic Competition for Lipitor Royal Endorsement for UAE’s Newest Drugmaker Pathway Genomics to Offer BRCA Test

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.